Orphazyme A/S (CPH: ORPHA)
Denmark
· Delayed Price · Currency is DKK 1,248.40
+49.00 (4.09%)
Oct 1, 2024, 4:47 PM CET
Orphazyme Company Description
Orphazyme A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is based in Herlev, Denmark.
Orphazyme A/S
| Country | Denmark |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Jakob Bendtsen |
Contact Details
Address: Visionhouse Herlev, Capital Region of Denmark 2730 Denmark | |
| Website | orphazyme.com |
Stock Details
| Ticker Symbol | ORPHA |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0060910917 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jakob Færch Bendtsen | Chief Executive Officer and Director |